{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:49:27Z","timestamp":1772779767760,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["026\/15"],"award-info":[{"award-number":["026\/15"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11046-019-0317-6","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T11:15:57Z","timestamp":1547118957000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-1647","authenticated-orcid":false,"given":"Tatiana Borba","family":"Spader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Ram\u00edrez-Castrill\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney Hartz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Carlos","family":"Severo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"3","key":"317_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1099\/00207713-51-3-1191","volume":"51","author":"SK Biswas","year":"2001","unstructured":"Biswas SK, Yokoyama K, Nishimura K, Miyaji M. Molecular phylogenetics of the genus Rhodotorula and related basidiomycetous yeasts inferred from the mitochondrial cytochrome b gene. Int J Syst Evol Microbiol. 2001;51(3):1191\u20139.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"1","key":"317_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1399-3062.2011.00647.x","volume":"14","author":"T Mori","year":"2012","unstructured":"Mori T, Nakamura Y, Kato J, et al. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2012;14(1):91\u20134.","journal-title":"Transpl Infect Dis."},{"key":"317_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1130-1406(08)70032-9","volume":"25","author":"FF Tuon","year":"2008","unstructured":"Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol. 2008;25:135\u201340.","journal-title":"Rev Iberoam Micol."},{"issue":"1","key":"317_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/JCM.43.1.476-478.2005","volume":"43","author":"DJ Diekema","year":"2005","unstructured":"Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol. 2005;43(1):476\u20138.","journal-title":"J Clin Microbiol"},{"key":"317_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mmcr.2014.08.006","volume":"6","author":"S Tsiodras","year":"2014","unstructured":"Tsiodras S, Papageorgiou S, Meletiadis J, et al. Rhodotorula mucilaginosa associated meningitis: a subacute entity with high mortality. Case report and review. Med Mycol Case Rep. 2014;6:46\u201350.","journal-title":"Med Mycol Case Rep."},{"issue":"1","key":"317_CR6","first-page":"22","volume":"81","author":"A Ahmed","year":"1998","unstructured":"Ahmed A, Aggarwal M, Chiu R, Ramratnam B, Rinaldi M, Flanigan TP. A fatal case of Rhodotorula meningitis in AIDS. Med Health R I. 1998;81(1):22\u20133.","journal-title":"Med Health R I."},{"issue":"6","key":"317_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/13693780801972490","volume":"46","author":"GMD Almeida De","year":"2008","unstructured":"De Almeida GMD, Costa SF, Melhem M, et al. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol. 2008;46(6):547\u201356.","journal-title":"Med Mycol."},{"key":"317_CR8","first-page":"315","volume":"18","author":"T White","year":"1990","unstructured":"White T, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protoc: Guide Methods Appl. 1990;18:315\u201322.","journal-title":"PCR Protoc: Guide Methods Appl"},{"issue":"7\u20138","key":"317_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1439-0507.2000.00587.x","volume":"43","author":"K Fekete-Forg\u00e1cs","year":"2000","unstructured":"Fekete-Forg\u00e1cs K, Gy\u00fcre L, Lenkey B. Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses. 2000;43(7\u20138):273\u20139.","journal-title":"Mycoses"},{"key":"317_CR10","first-page":"1","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI document M27-A3","author":"Clinical Laboratory and Standards Institute","year":"2008","unstructured":"Clinical Laboratory and Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI document M27-A3. 3rd ed. Wayne: Clinical Laboratory and Standards Institute; 2008. p. 1\u201340.","edition":"3"},{"key":"317_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jac\/dkh434","volume":"54","author":"M Cuenca-Estrella","year":"2004","unstructured":"Cuenca-Estrella M. Combinations of antifungal agents in therapy\u2014what value are they? J Antimicrob Chemother. 2004;54:854\u201369.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"317_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/0929867321666131218094848","volume":"21","author":"R Musiol","year":"2014","unstructured":"Musiol R, Mrozek-Wilczkiewicz A, Polanski J. Synergy against fungal pathogens: working together is better than working alone. Curr Med Chem. 2014;21(7):870\u201393.","journal-title":"Curr Med Chem"},{"issue":"7","key":"317_CR13","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1128\/AAC.02623-13","volume":"58","author":"AS Oliveira","year":"2014","unstructured":"Oliveira AS, Gaspar CA, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A. Anti-Candida activity of fluoxetine alone and combined with fluconazole: a synergistic action against fluconazole-resistant strains. Antimicrob Agents Chemother. 2014;58(7):4224\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"317_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","volume":"48","author":"MD Johnson","year":"2004","unstructured":"Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Combination antifungal therapy. Antimicrob Agents Chemother. 2004;48(3):693\u2013715.","journal-title":"Antimicrob Agents Chemother"},{"key":"317_CR15","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419\u201331.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"317_CR16","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1128\/JCM.41.11.5233-5235.2003","volume":"41","author":"AK Zaas","year":"2003","unstructured":"Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol. 2003;41(11):5233\u20135.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"317_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","volume":"49","author":"D Ellis","year":"2002","unstructured":"Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49(Suppl 1):7\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"317_CR18","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/AAC.43.4.836","volume":"43","author":"SA Yoon","year":"1999","unstructured":"Yoon SA, Vazquez JA, Steffan PE, Sobel JD, Akins RA. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 1999;43(4):836\u201345.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2\u20133","key":"317_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.funbio.2009.12.003","volume":"114","author":"R Kumar","year":"2010","unstructured":"Kumar R, Shukla PK. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans. Fungal Biol. 2010;114(2\u20133):189\u201397.","journal-title":"Fungal Biol."},{"issue":"2","key":"317_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jac\/dkh336","volume":"54","author":"KS Barker","year":"2004","unstructured":"Barker KS, Crisp S, Wiederhold N, et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother. 2004;54(2):376\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"317_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1473-3099(07)70111-1","volume":"7","author":"M Terblanche","year":"2007","unstructured":"Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infectious Diseases. 2007;7(5):358\u201368.","journal-title":"Lancet Infectious Diseases."},{"issue":"1","key":"317_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","volume":"30","author":"ME Cabral","year":"2013","unstructured":"Cabral ME, Figueroa LIC, Fari\u00f1a JI. Synergistic antifungal activity of statin\u2013azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification. Rev Iberoam Micol. 2013;30(1):31\u20138.","journal-title":"Rev Iberoam Micol."},{"issue":"5","key":"317_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","volume":"19","author":"RSN Brilhante","year":"2015","unstructured":"Brilhante RSN, Caetano EP, de Oliveira JS, et al. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species. Brazilian J Infect Dis. 2015;19(5):459\u201365.","journal-title":"Brazilian J Infect Dis."},{"issue":"1","key":"317_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","volume":"50","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006;50(1):96\u2013103.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"317_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13693786.2013.828160","volume":"52","author":"I Nyilasi","year":"2013","unstructured":"Nyilasi I, Kocsub\u00e9 S, Krizs\u00e1n K, et al. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Med Mycol. 2013;52(2):1\u20139.","journal-title":"Med Mycol"},{"issue":"6","key":"317_CR26","doi-asserted-by":"publisher","first-page":"e0157047","DOI":"10.1371\/journal.pone.0157047","volume":"11","author":"S Yang","year":"2016","unstructured":"Yang S, Liao Y, Cong L, Lu X, Yang R. In vitro interactions between non-steroidal anti-inflammatory drugs and antifungal agents against planktonic and biofilm forms of Trichosporon asahii. PLoS ONE. 2016;11(6):e0157047.","journal-title":"PLoS ONE"},{"issue":"2","key":"317_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.diagmicrobio.2011.05.007","volume":"71","author":"TP Venturini","year":"2011","unstructured":"Venturini TP, Rossato L, Spader TB, et al. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp. Diagn Microbiol Infect Dis. 2011;71(2):126\u201330.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"317_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/EC.00302-13","volume":"13","author":"YL Chen","year":"2014","unstructured":"Chen YL, Yu SJ, Huang HY, et al. Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis. Eukaryot Cell. 2014;13(7):844\u201354.","journal-title":"Eukaryot Cell"},{"issue":"3","key":"317_CR29","doi-asserted-by":"publisher","first-page":"e0150859","DOI":"10.1371\/journal.pone.0150859","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, Yue L, Gu W, Li X, Zhang L, Sun S. Synergistic effect of fluconazole and calcium channel blockers against resistant Candida albicans. PLoS ONE. 2016;11(3):e0150859.","journal-title":"PLoS ONE"},{"issue":"4","key":"317_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1099\/jmm.0.47651-0","volume":"57","author":"Q Guo","year":"2008","unstructured":"Guo Q, Sun S, Yu J, Li Y, Cao L. Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol. 2008;57(4):457\u201362.","journal-title":"J Med Microbiol"},{"issue":"4","key":"317_CR31","first-page":"577","volume":"122","author":"RH Hong","year":"2000","unstructured":"Hong RH, Koch RJ. Possible role of anticoagulation in the treatment of rhinocerebral mucormycosis. Otolaryngol Head Neck Surg. 2000;122(4):577\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"317_CR32","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1128\/AAC.03046-15","volume":"60","author":"W Gu","year":"2016","unstructured":"Gu W, Guo D, Zhang L, Xu D, Sun S. The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence. Antimicrob Agents Chemother. 2016;60(10):6179\u201388.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"317_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijantimicag.2004.03.021","volume":"24","author":"I Heller","year":"2004","unstructured":"Heller I, Leitner S, Dierich MP, Lass-Fl\u00f6rl C. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. Int J Antimicrob Agents. 2004;24(4):401\u20134.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"317_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1006986824213","volume":"19","author":"C Sanchez","year":"1999","unstructured":"Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol. 1999;19(4):467\u201389.","journal-title":"Cell Mol Neurobiol"},{"issue":"3\u20134","key":"317_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11046-014-9787-8","volume":"178","author":"D Mo","year":"2014","unstructured":"Mo D, Li X, Wei L, Sun C, Liang H, Cao C. In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei. Mycopathologia. 2014;178(3\u20134):217\u201320.","journal-title":"Mycopathologia"},{"issue":"Pt7","key":"317_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1099\/jmm.0.073478-0","volume":"63","author":"RA Cordeiro","year":"2014","unstructured":"Cordeiro RA, Macedo RB, Teixeira CEC, et al. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. J Med Microbiol. 2014;63(Pt7):936\u201344.","journal-title":"J Med Microbiol"},{"issue":"3","key":"317_CR37","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01397-07","volume":"52","author":"P Uppuluri","year":"2008","unstructured":"Uppuluri P, Nett J, Heitman J, Andes D. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother. 2008;52(3):1127\u201332.","journal-title":"Antimicrob Agents Chemother"},{"key":"317_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/AAC.01070-07","volume":"52","author":"S Sun","year":"2008","unstructured":"Sun S, Li Y, Guo QJ, Shi CW, Yu JL, Ma L. In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother. 2008;52:409\u201317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"317_CR39","first-page":"9","volume":"14","author":"MA Petrou","year":"1988","unstructured":"Petrou MA, Rogers TR. In-vitro activity of antifungal agents in combination with four quinolones. Drugs Exp Clin Res. 1988;14(1):9\u201318.","journal-title":"Drugs Exp Clin Res"},{"issue":"7","key":"317_CR40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1128\/AAC.39.7.1517","volume":"39","author":"R Nakajima","year":"1995","unstructured":"Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother. 1995;39(7):1517\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"317_CR41","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/jac\/dkg218","volume":"51","author":"RG Vitale","year":"2003","unstructured":"Vitale RG, Afeltra J, De Hoog GS, Rijs AJ, Verweij PE. In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera. J Antimicrob Chemother. 2003;51:1297\u2013300.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"317_CR42","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.41.11.2518","volume":"41","author":"AM Sugar","year":"1997","unstructured":"Sugar AM, Liu XP, Chen RJ. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. Antimicrob Agents Chemother. 1997;41(11):2518\u201321.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-019-0317-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-019-0317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-019-0317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T19:08:34Z","timestamp":1578596914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-019-0317-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1007\/s11046-019-0317-6","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"15 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that the data\/results of the manuscript do not constitute plagiarism and have not been published elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Genuinity"}},{"value":"This article does not contain any studies on human and animal performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}